Page last updated: 2024-09-05

sorafenib and reparixin

sorafenib has been researched along with reparixin in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(reparixin)
Trials
(reparixin)
Recent Studies (post-2010) (reparixin)
6,5207305,25170448

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)reparixin (IC50)
C-X-C chemokine receptor type 1Homo sapiens (human)0.0031
C-X-C chemokine receptor type 2Homo sapiens (human)0.0354

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cetin-Atalay, R; Kahraman, DC; Kahraman, T1

Other Studies

1 other study(ies) available for sorafenib and reparixin

ArticleYear
Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment.
    Molecular cancer therapeutics, 2019, Volume: 18, Issue:11

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Interleukin-8; Liver Neoplasms; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; Sorafenib; Sulfonamides; TOR Serine-Threonine Kinases

2019